Narayana Hrudayalaya Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
January 31, 2018 at 07:09 am
Share
Narayana Hrudayalaya Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, on a standalone basis, the company reported revenue from operations of INR 4,610.996 million compared to INR 3,968.045 million a year ago. Earnings before depreciation and amortization, finance costs and exceptional items was INR 490.373 million compared to INR 528.752 million a year ago. Profit before tax was INR 277.436 million compared to INR 302.146 million a year ago. Profit for the period was INR 178.653 million compared to INR 193.276 million a year ago. Basic and diluted earnings per share was INR 0.88 compared to INR 0.95 a year ago.
For the nine months, on a standalone basis, the company reported revenue from operations of INR 13,712.051 million compared to INR 12,231.823 million a year ago. Earnings before depreciation and amortization, finance costs and exceptional items was INR 1,536.355 million compared to INR 1,689.955 million a year ago. Profit before tax was INR 836.658 million compared to INR 1,079.115 million a year ago. Profit for the period was INR 540.877 million compared to INR 706.625 million a year ago. Diluted earnings per share were INR 2.66 compared to INR 3.48 a year ago.
For quarter, on a consolidated basis, the company reported revenue from operations was INR 5,538.372 million compared to INR 4,552.695 million a year ago. Earnings before depreciation and amortization, finance costs and exceptional items (EBITDA) was INR 551.701 million compared to INR 564.592 million a year ago. Profit before tax was INR 240.041 million compared to INR 279.215 million a year ago. Profit for the period was INR 141.258 million compared to INR 169.936 million a year ago. Profit attributable to owners of the company was INR 141.110 million compared to INR 170.173 million a year ago. Basic and diluted earnings per share were INR 0.70 compared to INR 0.84 a year ago. The company announced that till third quarter, Capex is around INR 720 millions. For the third quarter, the company registered a robust growth of 21.7% year-on-year in total operating income from INR 4,553 million to INR 5,538 million. It's really heartening to note that the bulk of this growth is on the foundation of solid and constant uptick in its volumes across the network. This showcases that the business is back on the high growth trajectory after registering an average growth amidst the temporary strutters in the form of demonetization and cap on cardiac stent prices in the last 4 quarters.
For nine months, the company reported revenue from operations was INR 16,341.106 million compared to INR 13,946.380 million a year ago. Earnings before depreciation and amortization, finance costs and exceptional items (EBITDA) was INR 1,746.113 million compared to INR 1,804.778 million a year ago. Profit before tax was INR 711.722 million compared to INR 980.793 million a year ago. Profit for the period was INR 415.941 million compared to INR 607.215 million a year ago. Profit attributable to owners of the company was INR 415.983 million compared to INR 607.834 million a year ago. Basic and diluted earnings per share were INR 2.05 compared to INR 3.00 a year ago. As on January 3rd, 2018, the consolidated net debt was INR 6,973 million. The company announced that till date nine months, it have spent around INR 700 millions towards normal routine maintenance and upgradation CapEx.
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
Narayana Hrudayalaya Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017